Harding Loevner LP Regeneron Pharmaceuticals, Inc. Transaction History

Harding Loevner LP

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $6,313 - $7,967	11 New	11 $8,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $6,314 - $7,490	-11 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $6,700 - $8,223	-15 Reduced 57.69%	11 $5,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $956 - $1,215	-2 Reduced 7.14%	26 $13,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $544 - $658	-1 Reduced 3.45%	28 $16,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $8.25 Million - $10.8 Million	-16,718 Reduced 99.83%	29 $18,000
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $199 Million - $292 Million	-590,595 Reduced 97.24%	16,747 $8.18 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $23.3 Million - $32 Million	-84,936 Reduced 12.27%	607,342 $228 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $781,548 - $909,958	2,858 Added 0.41%	692,278 $192 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $2.97 Million - $4.11 Million	-9,902 Reduced 1.42%	689,420 $216 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $6.92 Million - $8.17 Million	18,591 Added 2.73%	699,322 $287 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $14.7 Million - $17.7 Million	43,833 Added 6.88%	680,731 $254 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $6.41 Million - $7.46 Million	18,259 Added 2.95%	636,898 $257 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $1.97 Million - $2.39 Million	-6,925 Reduced 1.11%	618,639 $213 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $2 Million - $2.5 Million	-6,347 Reduced 1.0%	625,564 $216 Million
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $5.69 Million - $7.46 Million	-15,866 Reduced 2.45%	631,911 $238 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $1.3 Billion - $1.52 Billion	-3,015,771 Reduced 82.32%	647,777 $290 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $1.58 Billion - $1.85 Billion	3,663,548	3,663,548 $287 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account